David Kirske - Chief Financial Officer at X4 Pharmaceuticals, Inc

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Financial Officer
Issuer Symbol
XFOR on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by David Kirske since 30 Jan 2025

Holdings reported by David Kirske for X4 Pharmaceuticals, Inc

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 193,254 $757,555 $3.92 14 Aug 2025 Direct
Stock Option (right to buy) 1,552,769 29 Oct 2025 Direct Common Stock

Transactions reported by David Kirske for X4 Pharmaceuticals, Inc

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.